Table 7.
Laser | Filter | Fluorochrome | Antigen | Manufacturer | Clone | Dilutiona |
---|---|---|---|---|---|---|
488 nm | 515/20 | BB515 | CXCR5 | BD | RF8B2 | 140 |
710/50 | BB700 | CD4 | BD | SK3 | 160 | |
640 nm | 660/20 | AF647 | CLAb | Biolegend | HECA-452 | 200 |
660/20 | AF647 | SLeX (CD15S)b | BD | CSLEX1 | 200 | |
730/45 | AF700 | CXCR3 | Biolegend | G025H7 | 50 | |
780/60 | APC-Cy7 | CCR7 | Biolegend | G043H7 | 50 | |
355 nm | 379/28 | BUV395 | Ki67 | BD | B56 | 200 |
515/30 | BUV496 | CD8 | BD | RPA-T8 | 200 | |
586/15 | BUV563 | CD45RA | BD | HI100 | 200 | |
660/20 | BUV661 | CD38 | BD | HIT2 | 66.7 | |
740/35 | BUV737 | CD25 | BD | 2A3 | 200 | |
820/60 | BUV805 | CD3 | BD | UCHT1 | 200 | |
405 nm | 450/50 | BV421 | CCR6 | BD | 11A9 | 100 |
470/15 | BV480 | CD127 | BD | HIL-7R-M21 | 50 | |
515/20 | Aqua Blue | Viability | Invitrogen | n/a | 20 | |
515/20 | BV510 | CD14 | Biolegend | M5E2 | 200 | |
515/20 | BV510 | CD19 | Biolegend | HIB19 | 200 | |
586/15 | BV570 | CD27 | Biolegend | O323 | 50 | |
610/20 | BV605 | HLA-DR | BD | G46-6 | 100 | |
660/20 | BV650 | CCR5 | BD | 3A9 | 166.7 | |
710/50 | BV711 | CD95 | Biolegend | DX2 | 100 | |
780/60 | BV785 | PD-1 | Biolegend | EH12.2H7 | 50 | |
561 nm | 586/15 | PE | CD69 | BD | FN50 | 10 |
610/20 | PE-CF594 | CCR4 | BD | 1G1 | 100 | |
660/40 | PE-Cy5 | CXCR4 | BD | 12G5 | 40 | |
780/60 | PE-Cy7 | FoxP3 | eBioscience | 236A/E7 | 20 |
n/a, not applicable; BB, brilliant blue; AF, Alexa Fluor; APC, allophycocyanin; BUV; Brilliant Ultraviolet; BV, Brilliant Violet; PE, phycoerythrin.
Dilutions are calculated by titration of all antibodies. In some cases, antibody volumes/dilution factors are rounded up to facilitate pipetting (for example, CD38 BUV661 is used at a 1.5 μL/test or a 1:66.7 dilution).
This protocol indicates the staining of CLA AF647 and SLeX AF647 in two independent panels, not simultaneously in the same antibody cocktail.